ToGA研究证明联合曲妥珠单抗(T-mab)方案可以改善HER2阳性晚期胃癌患者的总生存。然而，尚无研究评估T-mab 联合S-1 加顺铂(SP)方案的有效性和安全性。
基于28个网页-相关网页
T-Rex MAB Michael Angelo 亲笔签名
Late Tuesday afternoon, the companies presented mediocre trial results showing that bapineuzumab (b-mab for short) didn't work overall in an 18-month second stage trial but seemed to help a subset of patients who lack a certain gene mutation, APOE4.
FORBES: Magazine Article
应用推荐
模块上移
模块下移
不移动